Briacell Therapeutics Corp

NASDAQ BCTX

Data sourced from iex and EODHD
Download Data

Briacell Therapeutics Corp Income Statement 2006 - 2024

This table shows the Income Statement for Briacell Therapeutics Corp going from 2006 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2017-01-31 2016-10-31 2016-07-31 2016-04-30 2016-01-31 2015-10-31 2015-07-31 2015-04-30 2015-01-31 2014-10-31 2014-07-31 2014-04-30 2014-01-31 2013-10-31 2013-07-31 2013-04-30 2013-01-31 2012-10-31 2012-07-31 2012-04-30 2012-01-31 2011-10-31 2011-07-31 2011-04-30 2011-01-31 2010-10-31 2010-07-31 2010-04-30 2010-01-31 2009-10-31 2009-07-31 2009-04-30 2009-01-31 2008-10-31 2008-07-31 2008-04-30 2008-01-31 2007-10-31 2007-07-31 2007-04-30 2007-01-31 2006-10-31 2006-07-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cost of Revenue
M 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Expenses
M 10 8 8 6 -3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 2 2 3 2 1 2 1 2 2 1 1 2 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Research and Development (R&D) Expenses
M 8 7 5 4 3 3 3 3 2 1 1 0 0 0 0 0 1 1 1 1 1 1 1 1 1 0 1 1 0 0 1 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M 0 0 0 0 -8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 10 8 8 6 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -10 -9 -8 -6 3 -5 -4 2 -4 -2 -2 -5 0 0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 -1 0 0 0 -1 0 0 0 0 0 0 0 0 0 -1 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense
M - - 14 1 15 0 0 12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - - - - - 0 0 0 - 0 0 0 - - - - - - 0 0 -
Non-operating Income/Expense
M -2 14 5 1 -15 4 -13 0 0 0 -1 8 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -2 -7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 - - 0 0 - - - - - - - -
EBT
M -11 6 -2 -5 -12 -1 -17 2 2 1 1 2 0 0 0 0 1 0 0 0 -1 -1 -2 -1 -1 0 -1 -1 0 0 0 0 -1 0 0 0 -2 0 -7 -1 0 0 0 0 0 0 0 0 0 0 -1 -1 0 - 0 -1 -1 0 0 - - 0 0 - - - - - - - -
Income Tax Provision
M 0 -15 5 -1 0 -4 0 12 0 0 -1 1 -8 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 7 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -11 20 -7 -4 -12 3 -18 -9 2 1 2 1 9 0 0 0 0 0 0 0 -2 -1 -1 -2 -1 -1 -1 -1 -1 0 0 -1 -1 -1 0 0 -2 -2 -15 -8 -1 0 0 0 0 0 -1 0 0 0 -1 -1 0 - -1 -1 -1 0 -1 - - 0 0 - - - - - - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M - - - -5 -12 -1 -16 -5 -4 -2 -3 4 0 -1 -1 -1 -2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 15,981,726.00 16,674,890.00 15,981,726.00 15,518,072.00 15,518,018.00 15,518,018.00 15,238,646.00 15,518,018.00 15,788,827.00 15,370,412.00 15,269,583.00 7,536,667.00 771,962.00 771,962.00 729.84 721,962.00 721,962.00 721,961.00 655.42 654,529.00 545,642.00 537,706.00 527.58 526,041.00 374,064.00 370,255.00 355,324.00 342,444.00 333,389.00 307,310.00 305,018.00 283,924.00 282,426.00 282,426.00 290,830.00 281,439.00 198,300.00 177,020.00 59,006.00 59,006.00 59,006.00 59,006.00 59,006.00 58,853.00 58,850.00 58,994.00 58,994.00 58,840.00 58,840.00 58,698.00 58,698.00 24,993.00 23,551.00 23,447.00 23,447.00 17,163.00 15,902.00 15,900.00 15,900.00 6,321.00 4,837.00 5,332.00 5,332.00 4,837.00 4,837.00 5,332.00 5,332.00 7,383.00 4,837.00 5,747.00 5,747.00
EBITDA
M -10 -23 -7 -5 3 -5 -17 2 2 1 1 2 0 0 0 0 1 0 0 0 -1 -1 -2 -1 -1 -1 -1 -1 0 0 0 0 -1 0 -1 0 1 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 0 0 0 0 0 0 -13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -10 -23 -7 -6 3 -5 -4 2 2 1 1 2 0 0 0 0 1 0 0 0 -1 -1 -2 0 0 0 -1 -1 0 0 0 0 -1 0 -1 0 1 2 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.35 -243.41 -199.48 10.79 0.00 388.29 -0.58 500.46 -0.29 -0.11 -116.84 47.16 -4,683.73 56.59 -0.39 23.59 39.74 110.75 7.02 111.63 -32.82 -27.85 28.83 -54.48 -69.11 -34.92 -1.78 -13.05 -99.99 -23.35 -14.29 -53.14 -21.74 -72.08 233.98 -18.87 -3.81 -1,643.01 -97.62 -1,462.88 -615.67 -3.73 -4.11 -10.77 8.30 30.20 -106.82 71.93 107.97 107.97 -5.00 -1.38 4.76 - -85.98 0.13 -0.12 60.56 -33.45 - - -22.77 -111.01 - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email